S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results

Goldman Sachs Future Health Care Equity ETF Rating

$34.16
+0.06 (+0.18%)
(As of 02/27/2024 ET)

Goldman Sachs Future Health Care Equity ETF Aggregate Rating and Price Target (2024)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

GDOC Aggregate Rating

Moderate Buy
2.65

Holdings in GDOC have an aggregate rating of Moderate Buy based on 552 analyst ratings issued in the past year covering 39 companies (82.1% of the portfolio).

GDOC Aggregate Price Target

$38.69
13.26% Upside
High Prediction$49.67
Average Prediction$38.69
Low Prediction$29.05

Holdings in GDOC have an aggregate price target of $38.69 and a range of $29.05 to $49.67 covering 39 companies (82.1% of the portfolio).

GDOC Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
Moderate Buy
24 Moderate Buy rating(s)
Hold
12 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Goldman Sachs Future Health Care Equity ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 39 GDOC Holdings

Weight
In ETF
CompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
7.60%
Eli Lilly and Companyd stock logo
LLY
Eli Lilly and Company
$765.00
-0.9%
5 of 5 stars
2.84$663.33 -13.3%19Gap Down
5.29%
Boston Scientific Co.d stock logo
BSX
Boston Scientific
$66.41
-0.4%
5 of 5 stars
3.00$66.05 -0.5%19Insider Selling
5.00%
Intuitive Surgical, Inc.d stock logo
ISRG
Intuitive Surgical
$386.46
-0.5%
5 of 5 stars
2.80$371.60 -3.8%20
3.58%
Biogen Inc.d stock logo
BIIB
Biogen
$223.94
+0.1%
5 of 5 stars
2.70$305.68 36.5%27Analyst Revision
3.29%
DexCom, Inc.d stock logo
DXCM
DexCom
$115.32
-0.7%
5 of 5 stars
2.92$134.64 16.8%13Positive News
3.08%
Gilead Sciences, Inc.d stock logo
GILD
Gilead Sciences
$73.02
+0.1%
5 of 5 stars
2.27$85.86 17.6%15
2.98%
BioMarin Pharmaceutical Inc.d stock logo
BMRN
BioMarin Pharmaceutical
$90.68
+0.6%
5 of 5 stars
2.65$109.74 21.0%20Earnings Report
2.90%
Seagen Inc.d stock logo
SGEN
Seagen
$228.74
0 of 5 stars
2.25$210.45 -8.0%12Analyst Report
2.87%
Bristol-Myers Squibbd stock logo
BMY
Bristol-Myers Squibb
$50.51
0.0%
5 of 5 stars
2.11$61.17 21.1%19
2.86%
The Cooper Companies, Inc.d stock logo
COO
Cooper Companies
$93.74
-0.8%
4 of 5 stars
2.60$100.33 7.0%10Upcoming Earnings
Stock Split
2.84%
Insulet Co.d stock logo
PODD
Insulet
$166.62
-1.3%
5 of 5 stars
2.81$250.33 50.2%16Earnings Report
Analyst Report
Analyst Revision
High Trading Volume
2.83%
Zimmer Biomet Holdings, Inc.d stock logo
ZBH
Zimmer Biomet
$126.37
-0.4%
5 of 5 stars
2.24$138.20 9.4%17Dividend Announcement
Insider Selling
2.49%
West Pharmaceutical Services, Inc.d stock logo
WST
West Pharmaceutical Services
$358.29
-1.4%
5 of 5 stars
2.80$435.20 21.5%5Dividend Announcement
Insider Selling
2.46%
Neurocrine Biosciences, Inc.d stock logo
NBIX
Neurocrine Biosciences
$136.03
+0.3%
5 of 5 stars
2.75$137.23 0.9%24
2.41%
Zoetis Inc.d stock logo
ZTS
Zoetis
$199.00
+1.0%
5 of 5 stars
3.00$224.33 12.7%8
2.37%
Mettler-Toledo International Inc.d stock logo
MTD
Mettler-Toledo International
$1,213.21
+1.5%
4 of 5 stars
2.20$1,223.71 0.9%5Insider Selling
2.19%
Veeva Systems Inc.d stock logo
VEEV
Veeva Systems
$222.84
-0.5%
5 of 5 stars
2.64$219.77 -1.4%22Upcoming Earnings
Analyst Report
2.14%
Illumina, Inc.d stock logo
ILMN
Illumina
$139.76
+2.0%
5 of 5 stars
2.32$166.95 19.5%19Insider Buying
2.12%
Danaher Co.d stock logo
DHR
Danaher
$255.01
+1.3%
4 of 5 stars
2.60$266.00 4.3%15Dividend Increase
Insider Selling
1.89%
Exact Sciences Co.d stock logo
EXAS
Exact Sciences
$56.90
-1.1%
5 of 5 stars
2.86$99.31 74.5%14Earnings Report
Analyst Downgrade
Analyst Revision
1.84%
Edwards Lifesciences Co.d stock logo
EW
Edwards Lifesciences
$86.50
+0.4%
5 of 5 stars
2.44$87.38 1.0%16Insider Selling
1.78%
Alexandria Real Estate Equities, Inc.d stock logo
ARE
Alexandria Real Estate Equities
$121.76
+2.2%
4 of 5 stars
2.88$137.13 12.6%8Positive News
1.77%
Genmab A/Sd stock logo
GMAB
Genmab A/S
$29.05
-1.2%
4 of 5 stars
2.38$48.50 67.0%13
1.53%
IDEXX Laboratories, Inc.d stock logo
IDXX
IDEXX Laboratories
$575.07
+0.9%
4 of 5 stars
2.67$591.50 2.9%9Positive News
1.48%
Align Technology, Inc.d stock logo
ALGN
Align Technology
$313.06
+0.7%
4 of 5 stars
2.44$336.27 7.4%9Analyst Report
1.43%
Alnylam Pharmaceuticals, Inc.d stock logo
ALNY
Alnylam Pharmaceuticals
$159.00
+0.2%
5 of 5 stars
2.58$216.12 35.9%19
1.32%
Halozyme Therapeutics, Inc.d stock logo
HALO
Halozyme Therapeutics
$39.84
+0.4%
5 of 5 stars
2.70$51.60 29.5%10
1.26%
Sarepta Therapeutics, Inc.d stock logo
SRPT
Sarepta Therapeutics
$141.53
+2.8%
4 of 5 stars
2.78$157.55 11.3%18Analyst Revision
1.15%
Stevanato Group S.p.A.d stock logo
STVN
Stevanato Group
€30.81
-5.7%
0 of 5 stars
2.717
1.01%
argenx SEd stock logo
ARGX
argenx
$411.20
+0.2%
4 of 5 stars
2.73$526.29 28.0%22Upcoming Earnings
0.81%
Agilent Technologies, Inc.d stock logo
A
Agilent Technologies
$132.55
+0.8%
4 of 5 stars
2.50$137.44 3.7%16Earnings Report
Dividend Announcement
News Coverage
0.68%
Shockwave Medical, Inc.d stock logo
SWAV
Shockwave Medical
$263.47
+1.4%
4 of 5 stars
2.75$259.38 -1.6%8Insider Selling
0.56%
Axonics, Inc.d stock logo
AXNX
Axonics
$68.31
-0.5%
4 of 5 stars
2.42$71.09 4.1%12News Coverage
Positive News
0.53%
Ultragenyx Pharmaceutical Inc.d stock logo
RARE
Ultragenyx Pharmaceutical
$53.66
+6.8%
5 of 5 stars
2.89$92.20 71.8%10Analyst Report
0.46%
2seventy bio, Inc.d stock logo
TSVT
2seventy bio
$5.96
+8.4%
3 of 5 stars
2.38$13.17 120.9%8
0.40%
iRhythm Technologies, Inc.d stock logo
IRTC
iRhythm Technologies
$118.43
+11.6%
2 of 5 stars
3.00$135.11 14.1%8
0.38%
MoonLake Immunotherapeuticsd stock logo
MLTX
MoonLake Immunotherapeutics
$54.76
+5.1%
2 of 5 stars
2.83$74.25 35.6%12Analyst Report
0.31%
Beam Therapeutics Inc.d stock logo
BEAM
Beam Therapeutics
$45.07
+25.9%
0 of 5 stars
2.38$43.92 -2.6%13Analyst Report
News Coverage
Gap Up
High Trading Volume
0.18%
Cytokinetics, Incorporatedd stock logo
CYTK
Cytokinetics
$80.99
+2.5%
3 of 5 stars
2.87$73.94 -8.7%15News Coverage
This page (NYSEARCA:GDOC) was last updated on 2/28/2024 by MarketBeat.com Staff